info@synchemia.com | sales@synchemia.com 
9766925136 
Clonixin Nitroso Impurity
Specifications
Product name
Clonixin Nitroso Impurity
SRC CAT No
SRC-N014476
CAS No
NA
Mol.F.
C13H10ClN3O3
Mol.Wt.
291.7
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
2-((3-Chloro-2-methylphenyl)(nitroso)amino)nicotinic acid
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Clonixin is an NSAID used to relieve pain associated with arthritis, migraines, and various soft tissue disorders. Clonixin is a non-steroidal anti-inflammatory drug.Clonixin Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Clonixin Nitroso CAS NO:NA chemically represented as 2-((3-Chloro-2-methylphenyl)(nitroso)amino)nicotinic acid . Synchemia is the leading manufacturing and exporter of Clonixin Nitroso . We supply Clonixin Nitroso with detailed characterization data compliance with regulatory guidelines.
Related Products
Acalabrutinib Nitroso Impurity 5
| CAT No | SRC-N0143364 |
| CAS No | NA |
| Mol.F. | C10H10ClN5O |
| Mol.Wt. | 251.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Acalabrutinib Nitroso Impurity 6
| CAT No | SRC-N0143365 |
| CAS No | NA |
| Mol.F. | C10H12ClN5O2 |
| Mol.Wt. | 269.7 g/mole |
| INV STATUS |
Methylpropylnitrosamine
| CAT No | SRC-N0143366 |
| CAS No | 924-46-9 |
| Mol.F. | C4H10N2O |
| Mol.Wt. | 102.1 g/mole |
| INV STATUS | In Stock |
N-Nitroso Bevantolol
| CAT No | SRC-N0143367 |
| CAS No | NA |
| Mol.F. | C20H26N2O5 |
| Mol.Wt. | 374.4 g/mole |
| INV STATUS | In Stock |
N-Nitroso Vortioxetine Impurity 1
| CAT No | SRC-N0143368 |
| CAS No | NA |
| Mol.F. | C18H21N3OS |
| Mol.Wt. | 327.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Nirogacestat Impurity 2
| CAT No | SRC-N0143369 |
| CAS No | NA |
| Mol.F. | C15H18ClFN2O3 |
| Mol.Wt. | 328.77 g/mole |
| INV STATUS | UNDER SYNTHESIS |
N-Nitroso Nirogacestat Impurity 3
| CAT No | SRC-N0143370 |
| CAS No | NA |
| Mol.F. | C12H23N5O |
| Mol.Wt. | 253.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Nirogacestat Impurity 8
| CAT No | SRC-N0143371 |
| CAS No | NA |
| Mol.F. | C27H40ClFN6O2 |
| Mol.Wt. | 535.11g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Nirogacestat Impurity 9
| CAT No | SRC-N0143372 |
| CAS No | NA |
| Mol.F. | C27H40ClFN6O2 |
| Mol.Wt. | 535.11g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
2,2-dimethyl-N-[2-methyl-2-(4-nitro-1H-imidazol-1-yl)propyl]-N-nitrosopropan-1-amine
| CAT No | SRC-N0143373 |
| CAS No | NA |
| Mol.F. | C12H21N5O3 |
| Mol.Wt. | 283.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
(2S)-2-{[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl](nitroso)amino}pentanoic acid
| CAT No | SRC-N0143374 |
| CAS No | NA |
| Mol.F. | C15H18F2N2O3 |
| Mol.Wt. | 312.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso N-Desethyl-N-Methyl Vardenafil
.png)
| CAT No | SRC-N0143375 |
| CAS No | NA |
| Mol.F. | C21H27N7O5S |
| Mol.Wt. | 489.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Vardenafil Dessulfonyl Impurity
.png)
| CAT No | SRC-N0143376 |
| CAS No | NA |
| Mol.F. | C17H19N5O3 |
| Mol.Wt. | 341.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Vardenafil EP Impurity A
.png)
| CAT No | SRC-N0143377 |
| CAS No | NA |
| Mol.F. | C21H27N7O5S |
| Mol.Wt. | 489.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Vardenafil EP Impurity B
| CAT No | SRC-N0143378 |
| CAS No | NA |
| Mol.F. | C17H19N5O6S |
| Mol.Wt. | 421.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Vardenafil EP Impurity C
| CAT No | SRC-N0143379 |
| CAS No | NA |
| Mol.F. | C38H45N11O9S2 |
| Mol.Wt. | 863.97 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
